Loading...

PerCP/Cyanine5.5 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PerCPCyanine55_CD11b_Antibody_111918
C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
  • M1slash70_PerCPCyanine55_CD11b_Antibody_111918
    C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
101227 25 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101228 100 µg 234€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  2. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  3. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  4. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  5. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  6. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  7. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  8. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  9. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  10. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  11. Orberg E, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.53. PubMed
  12. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  13. Milasan A, et al. 2017. J Am Heart Assoc. 10.1161/JAHA.117.006892. PubMed
  14. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  15. Lang J, et al. 2020. Nat Commun. 11:1338. PubMed
  16. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  17. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  18. Huang X, et al. 2021. Stem Cells Int. 2021:8138374. PubMed
  19. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  20. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  21. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  22. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  23. Ortiz G, et al. 2020. Front Immunol. 11:1713. PubMed
  24. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  25. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  26. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  27. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  28. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  29. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  30. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  31. Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
  32. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  33. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  34. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  35. Dong L, et al. 2021. Cancer Cell. . PubMed
  36. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  37. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  38. Chen L, et al. 2019. Cell Mol Gastroenterol Hepatol. 7:623. PubMed
  39. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  40. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  41. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  42. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  43. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  44. Biswas S, et al. 2021. Nature. 591:464. PubMed
  45. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  46. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  47. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  48. Amano C, et al. 2015. PLoS One. 10: 0137207. PubMed
  49. Sun P, et al. 2015. J Hepatol. . PubMed
  50. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  51. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  52. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  53. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  54. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  55. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  56. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  57. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  58. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  59. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  60. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  61. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  62. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  63. Lu S, et al. 2020. JCI Insight. 5:00. PubMed
  64. Koh EH, et al. 2018. Diabetes. 67(12). PubMed
  65. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  66. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  67. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  68. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  69. Plein A, et al. 2018. Nature. 562:223. PubMed
  70. Xu G, et al. 2022. Cell Death Dis. 13:888. PubMed
  71. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  72. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
  73. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  74. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  75. Nishi C, et al. 2014. Mol Cell Biol. 34:1512. PubMed
  76. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  77. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  78. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  79. Lu CY, et al. 2020. J Neurosci. 40:9602. PubMed
  80. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  81. Qian SJ, et al. 2021. Front Immunol. 12:711337. PubMed
  82. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  83. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  84. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  85. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  86. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  87. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  88. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  89. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  90. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  91. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  92. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  93. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  94. Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
  95. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  96. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  97. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  98. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  99. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  100. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  101. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  102. Lu S, et al. 2020. Arterioscler Thromb Vasc Biol. 40:394. PubMed
  103. Sun L, et al. 2015. J Immunol. 194:4891. PubMed
  104. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  105. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  106. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  107. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  108. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  109. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  110. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  111. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  112. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  113. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  114. Deczkowska A, et al. 2017. Nat Commun. 8:717. PubMed
  115. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  116. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  117. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  118. Cruz-Herranz A, et al. 2021. JCI Insight. 6: . PubMed
  119. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  120. Stowe CL, et al. 2019. eLife. 0.333333333333333. PubMed
  121. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  122. Grauel AL, et al. 2020. Nat Commun. 4.84375. PubMed
  123. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  124. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  125. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  126. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  127. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  128. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  129. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  130. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  131. Chruewkamlow N, et al. 2021. Stem Cell Res Ther. 12:520. PubMed
  132. Vachon L, et al. 2022. Theranostics. 12:1440. PubMed
  133. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  134. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  135. Ni C, et al. 2021. Infect Immun. 89:. PubMed
  136. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  137. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  138. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  139. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  140. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  141. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  142. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  143. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  144. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  145. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  146. Raoof R, et al. 2021. J Neurosci. 41:8249. PubMed
  147. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  148. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  149. Sharif O, et al. 2013. J Immunol. 190:5640. PubMed
  150. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  151. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  152. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  153. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  154. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  155. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  156. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  157. Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed
  158. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  159. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  160. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  161. Yang X, et al. 2018. Sci Rep. 8:188. PubMed
  162. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  163. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  164. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  165. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  166. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  167. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  168. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  169. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  170. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  171. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  172. Gu H, et al. 2021. Elife. 10:. PubMed
  173. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  174. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  175. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  176. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  177. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  178. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  179. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  180. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  181. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  182. Tothova Z et al. 2017. Cell stem cell. 21(4):547-555 . PubMed
  183. Molgora M, et al. 2020. Cell. 182:886. PubMed
  184. Werner A, et al. 2021. iScience. 24:103076. PubMed
  185. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  186. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  187. Chen J, et al. 2017. Sci Rep. 10.1038/s41598-017-00654-2. PubMed
  188. Danzer H, et al. 2020. Elife. 9:00. PubMed
  189. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  190. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  191. Starr T, et al. 2018. PLoS One. 13:e0193601. PubMed
  192. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  193. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  194. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  195. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  196. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  197. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  198. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  199. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  200. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  201. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  202. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  203. McDonald MM, et al. 2021. Cell. 184(5):1330-1347.e13. PubMed
  204. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  205. Guey B, et al. 2014. Proc Natl Acad Sci U S A. 111:17254. PubMed
  206. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  207. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  208. Bohlen CJ et al. 2017. Neuron. 94(4):759-773 . PubMed
  209. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  210. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  211. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  212. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  213. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  214. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  215. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  216. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  217. Lee J, et al. 2015. Nat Commun. 6: 8499. PubMed
  218. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
  219. Liddelow S, et al. 2017. Nature. 541:481-487. PubMed
  220. Xu Z, et al. 2020. Cell Rep. 32:108041. PubMed
  221. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  222. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  223. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  224. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  225. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  226. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  227. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  228. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  229. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  230. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  231. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  232. Strattan E, et al. 2020. Frontiers in Immunology. 2.131944444. PubMed
  233. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  234. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  235. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  236. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_893233 (BioLegend Cat. No. 101227)
AB_893232 (BioLegend Cat. No. 101228)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 11-19-2018

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account